Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profiling Interactions Between Bicyclol and SLC/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy. | Pharm Res | 2025 | 41145746 | PubTator, text mining | PubMed |
| [Effect of the combination of alkaloids from Euodiae Fructus and berberine in Zuojin Pill on cytotoxicity in HepG2 cells]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2025 | 41131764 | PubTator, text mining | PubMed |
| Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic review. | Fitoterapia | 2025 | 41106787 | PubTator, text mining | PubMed |
| How useful are the biochemical tests in guiding the diagnostic workup of infantile cholestasis? | Saudi J Gastroenterol | 2025 | 41090521 | PubTator, text mining | PubMed |
| Industry Perspective on Nonclinical Approaches for Hepatotoxicity Risk Assessment: Insights from Two Longitudinal Surveys Conducted in 2023 and 2017. | Chem Res Toxicol | 2025 | 41081640 | PubTator, text mining | PubMed |
| [Genetic analysis of a child with Progressive familial intrahepatic cholestasis type II due to a homozygous variant of ABCB11 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41070655 | PubTator, text mining | PubMed |
| Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cells. | Stem Cell Res Ther | 2025 | 41057965 | PubTator, text mining | PubMed |
| Improved allele frequencies in gnomAD through local ancestry inference. | Nat Commun | 2025 | 41053080 | PubTator, text mining | PubMed |
| A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis. | J Biol Chem | 2025 | 41033550 | PubTator, text mining | PubMed |
| iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis. | Hepatol Commun | 2025 | 41021273 | PubTator, text mining | PubMed |
| Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and rats. | Sci Rep | 2025 | 40998954 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study. | BJC Rep | 2025 | 40957947 | PubTator, text mining | PubMed |
| First Report of Living Donor Liver Transplantation for NR1H4 Disease. | Pediatr Transplant | 2025 | 40947515 | PubTator, text mining | PubMed |
| Observational suspected adverse drug reaction profiles of fluoro-pharmaceuticals and potential mimicry of per- and polyfluoroalkyl substances (PFAS) in the United Kingdom. | PLoS One | 2025 | 40892740 | PubTator, text mining | PubMed |
| Improving resident physicians' knowledge of the ABCDEF bundle through a multimodal teaching intervention. | Int J Med Educ | 2025 | 40888620 | PubTator, text mining | PubMed |
| A Rare ABCB5 Variant in a Familial Case of Intrahepatic Cholestasis of Pregnancy: A Potential Novel Genetic Contributor. | J Clin Med | 2025 | 40869443 | PubTator, text mining | PubMed |
| Dual Effects of Maternal Diet and Perinatal Organophosphate Flame Retardant Treatment on Offspring Development, Behavior and Metabolism. | Toxics | 2025 | 40863915 | PubTator, text mining | PubMed |
| Elafibranor for primary biliary cholangitis: a dual PPAR agonist changing the treatment landscape. | Ann Med Surg (Lond) | 2025 | 40851978 | PubTator, text mining | PubMed |
| Treatment of Inborn Errors by Product Replacement: The Example of Inborn Errors of Bile Acid Synthesis. | J Inherit Metab Dis | 2025 | 40847535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=5